312 related articles for article (PubMed ID: 17557866)
21. Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori.
Satoh K; Mutoh H; Eda A; Yanaka I; Osawa H; Honda S; Kawata H; Kihira K; Sugano K
Helicobacter; 2002 Jun; 7(3):192-8. PubMed ID: 12047325
[TBL] [Abstract][Full Text] [Related]
22. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
23. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
[TBL] [Abstract][Full Text] [Related]
24. Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis.
Sue S; Shibata W; Kameta E; Sato T; Ishii Y; Kaneko H; Miwa H; Sasaki T; Tamura T; Kondo M; Maeda S
J Gastroenterol; 2016 Oct; 51(10):949-60. PubMed ID: 26872890
[TBL] [Abstract][Full Text] [Related]
25. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
He XX; Yang J; Ding YW; Liu W; Shen QY; Xia HH
Gut; 2006 Jun; 55(6):797-802. PubMed ID: 16488898
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
27. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia.
Tava F; Luinetti O; Ghigna MR; Alvisi C; Perego M; Trespi E; Klersy C; Fratti C; Fiocca R; Solcia E
Hum Pathol; 2006 Nov; 37(11):1489-97. PubMed ID: 16949645
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of apoptosis along with BCL-2 and Ki-67 expression in patients with intestinal metaplasia.
Erkan G; Gonul II; Kandilci U; Dursun A
Pathol Res Pract; 2012 Feb; 208(2):89-93. PubMed ID: 22277792
[TBL] [Abstract][Full Text] [Related]
29. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
[TBL] [Abstract][Full Text] [Related]
30. Follow-Up Study on CDX1 and CDX2 mRNA Expression in Noncancerous Gastric Mucosae After Helicobacter pylori Eradication.
Shin CM; Kim N; Chang H; Kim JS; Lee DH; Jung HC
Dig Dis Sci; 2016 Apr; 61(4):1051-9. PubMed ID: 26841784
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between Helicobacter pylori infection and expression of c-myc, Bcl-2, and Bax protein in different gastric mucosa lesions].
Zhan N; Xiong YY; Lan J; Wang BC; Tian SF; Yu SP
Ai Zheng; 2003 Oct; 22(10):1034-7. PubMed ID: 14558945
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation.
Yoon JH; Choi SS; Kim O; Choi WS; Park YK; Nam SW; Lee JY; Park WS
Mod Pathol; 2016 Feb; 29(2):194-208. PubMed ID: 26743476
[TBL] [Abstract][Full Text] [Related]
33. [Down-regulation of Caspase-3 expression in precancerous lesions and its relation to gastric carcinogenesis].
Yang L; Wu DY; Xin Y
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):357-60. PubMed ID: 17045000
[TBL] [Abstract][Full Text] [Related]
34. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
35. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration.
Sakitani K; Hirata Y; Watabe H; Yamada A; Sugimoto T; Yamaji Y; Yoshida H; Maeda S; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Oct; 26(10):1570-5. PubMed ID: 21575058
[TBL] [Abstract][Full Text] [Related]
36. Epithelial cell turnover in relation to ongoing damage of the gastric mucosa in patients with early gastric cancer: increase of cell proliferation in paramalignant lesions.
Shiotani A; Iishi H; Ishiguro S; Tatsuta M; Nakae Y; Merchant JL
J Gastroenterol; 2005 Apr; 40(4):337-44. PubMed ID: 15870969
[TBL] [Abstract][Full Text] [Related]
37. Caudal type homeoboxes as a driving force in
Chen HY; Hu Y; Lu NH; Zhu Y
Gut Microbes; 2020 Nov; 12(1):1-12. PubMed ID: 33031021
[TBL] [Abstract][Full Text] [Related]
38. Compartment theory in Helicobacter pylori-associated gastric carcinogenesis.
Tseng HH; Hsu PI; Chen HC; Lai KH; Lo GH; Lo CC; Chou NH; Mok KT; Chen IS; Chou NH; Yang HB; Liu L; Hsu PN
Anticancer Res; 2003; 23(4):3223-9. PubMed ID: 12926056
[TBL] [Abstract][Full Text] [Related]
39. [Expression of peroxisome proliferators-activated receptor-gamma and cyclooxygenase-2 in Helicobacter pylori infection-associated diseases and significance thereof].
Xie Y; Zhu J; Zhou XJ; Chen J; Lu NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2683-9. PubMed ID: 17199977
[TBL] [Abstract][Full Text] [Related]
40. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.
Shin CM; Kim N; Lee HS; Park JH; Ahn S; Kang GH; Kim JM; Kim JS; Lee DH; Jung HC
Int J Cancer; 2013 Nov; 133(9):2034-42. PubMed ID: 23595635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
